Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β2-Agonist-Only Treatment
- PMID: 35202554
- PMCID: PMC9838624
- DOI: 10.1164/rccm.202111-2465LE
Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β2-Agonist-Only Treatment
Comment in
-
Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β2-Agonist-Only Treatment.Am J Respir Crit Care Med. 2022 Apr 15;205(8):972-973. doi: 10.1164/rccm.202112-2788LE. Am J Respir Crit Care Med. 2022. PMID: 35202561 Free PMC article. No abstract available.
Comment on
-
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.Am J Respir Crit Care Med. 2022 Jan 1;205(1):17-35. doi: 10.1164/rccm.202109-2205PP. Am J Respir Crit Care Med. 2022. PMID: 34658302 Free PMC article.
References
-
- Carroll W, Clayton S, Frost S, Gupta A, Holmes S, Nagakumar P, et al. If it’s “only” asthma, why are children still dying? Arch Dis Child . 2020;105:494–498. - PubMed
-
- Kersten ETG, Koppelman GH, Thio BJ. Concerns with beta2-agonists in pediatric asthma—a clinical perspective. Paediatr Respir Rev . 2017;21:80–85. - PubMed
-
- Bush A, Dalziel SR, Byrnes CA, Hatter L, Beasley R. Has the time come to end use of the blue inhaler? Lancet Respir Med . 2021;9:e51. - PubMed
-
- Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med . 2007;176:858–864. - PubMed